Biotech

All Articles

Gene editor Volume giving up 131 workers

.Simply days after genetics editor Tome Biosciences announced confidential working cuts, a clearer i...

Repare gives up 25% of team as biotech halts preclinical R&ampD

.Repare Rehab is giving up a quarter of its labor force as the oncology biotech lessen its own precl...

J &amp J apply for FDA confirmation of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually gotten yet another step toward understanding a yield on its $6.5 ...

Gain's period 1 gain leads way to show Parkinson's medication's worth

.Increase Rehabs has actually established its sights on verifying the performance of its Parkinson's...

Actinogen records new phase 2 information to save clinical depression drug

.Actinogen Medical's hopes-- as well as supply cost-- have recoiled slightly coming from earlier thi...

Pfizer as well as Crown jewel add Quotient to multibillion-dollar equation

.Flagship Pioneering as well as Pfizer have actually included Ratio into their 10-program partnershi...

Bayer pens $547M pact to push boundaries of noncoding RNA

.Bayer executives were eager to worry to Brutal this summertime that the German pharma titan's cravi...

UK unveils strategies to launch 18 new medical trial hubs

.Amid a yearslong medical test decline in the U.K., a brand new public-private relationship has actu...

UPDATE: Genentech telegraphs 93 cutbacks in The golden state after sharing plans to shutter cancer cells immunology research study unit

.Complying with the news of a huge unemployment round in April and a primary rebuilding project intr...

Neurocrine's KarXT rival strikes in stage 2-- but simply at reduced dose

.Neurocrine Biosciences has actually accomplished its own hoped-for profile in a stage 2 schizophren...